Eisai Co., Ltd. and Biogen Inc. announced today that results from the real-world Lecanemab in Early Alzheimer's Disease (LEADER) Study show that nearly 83% of early Alzheimer's disease (AD) patients ...
New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and ...
(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...
This article was updated with more information. The 2.7 million Florida customers of Progressive Insurance will see about $1 billion in rebate credits in 2026 — but the exact amount each policyholder ...
When a loved one passes, those who are living can be left with hefty burial costs. The average cost of a funeral in the U.S. can fall between $6,000 and $8,500, according to the National Funeral ...
Life insurance can help you replace lost income, pay off large debts or leave a financial legacy after you die. But there are many policy types to choose from, plus coverage limits, eligibility ...
LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results